Business Description
Yunnan Biovalley Pharmaceutical Co Ltd
ISIN : CNE100003YS1
Total Employee Number:
480Compare
Compare
Traded in other countries / regions
920266.China IPO Date
2020-07-27Description
Yunnan Biovalley Pharmaceutical Co Ltd engages in research and development, production, and marketing of pharmaceuticals and health care based on herbal medicines. The products on the market include breviscapine injection, breviscapine Shengmai capsules, breviscapine tablets, breviscapine dripping pills, Erigeron Capsules, Erigeron Soft Capsules.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 9.67 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.34 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.08 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9 | |||||
3-Year EBITDA Growth Rate | 20.7 | |||||
3-Year FCF Growth Rate | 21.6 | |||||
3-Year Book Growth Rate | -3.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.14 | |||||
9-Day RSI | 48.19 | |||||
14-Day RSI | 50.39 | |||||
3-1 Month Momentum % | 10.21 | |||||
6-1 Month Momentum % | -9.28 | |||||
12-1 Month Momentum % | -29.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.26 | |||||
Quick Ratio | 4.92 | |||||
Cash Ratio | 1.2 | |||||
Days Inventory | 228.88 | |||||
Days Sales Outstanding | 143.12 | |||||
Days Payable | 62.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.1 | |||||
Shareholder Yield % | 3.09 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.79 | |||||
Operating Margin % | -2.89 | |||||
Net Margin % | -6.49 | |||||
EBITDA Margin % | -5.85 | |||||
FCF Margin % | -13.01 | |||||
OCF Margin % | -9.64 | |||||
ROE % | -3.13 | |||||
ROA % | -2.6 | |||||
ROIC % | -1.42 | |||||
3-Year ROIIC % | 51.58 | |||||
ROC (Joel Greenblatt) % | -3.85 | |||||
ROCE % | -2.6 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.1 | |||||
PB Ratio | 1.07 | |||||
Price-to-Tangible-Book | 1.19 | |||||
EV-to-EBIT | -34.67 | |||||
EV-to-EBITDA | -34.67 | |||||
EV-to-Revenue | 2.03 | |||||
EV-to-FCF | -15.59 | |||||
Price-to-GF-Value | 0.97 | |||||
Price-to-Projected-FCF | 1.48 | |||||
| Price-to-Net-Current-Asset-Value | 3.26 | |||||
Earnings Yield (Greenblatt) % | -2.88 | |||||
FCF Yield % | -5.91 | |||||
Forward Rate of Return (Yacktman) % | -11.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yunnan Biovalley Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 426.238 | ||
| EPS (TTM) (Â¥) | -0.23 | ||
| Beta | 0.6596 | ||
| 3-Year Sharpe Ratio | 0.14 | ||
| 3-Year Sortino Ratio | 0.24 | ||
| Volatility % | 30.1 | ||
| 14-Day RSI | 50.39 | ||
| 14-Day ATR (Â¥) | 0.548564 | ||
| 20-Day SMA (Â¥) | 7.478 | ||
| 12-1 Month Momentum % | -29.34 | ||
| 52-Week Range (Â¥) | 6.04 - 11.84 | ||
| Shares Outstanding (Mil) | 124 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Yunnan Biovalley Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Yunnan Biovalley Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Yunnan Biovalley Pharmaceutical Co Ltd Frequently Asked Questions
What is Yunnan Biovalley Pharmaceutical Co Ltd(BJSE:920266)'s stock price today?
The current price of BJSE:920266 is ¥7.57. The 52 week high of BJSE:920266 is ¥11.84 and 52 week low is ¥6.04.
When is next earnings date of Yunnan Biovalley Pharmaceutical Co Ltd(BJSE:920266)?
The next earnings date of Yunnan Biovalley Pharmaceutical Co Ltd(BJSE:920266) is .
Does Yunnan Biovalley Pharmaceutical Co Ltd(BJSE:920266) pay dividends? If so, how much?
Yunnan Biovalley Pharmaceutical Co Ltd(BJSE:920266) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Yunnan Biovalley Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers